1186 related articles for article (PubMed ID: 2858494)
21. Clinical significance of the growth hormone response to vasoactive intestinal peptide and gonadotropin-releasing hormone in acromegaly.
Watanobe H; Tamura T
Neuropeptides; 1995 Feb; 28(2):115-24. PubMed ID: 7746355
[TBL] [Abstract][Full Text] [Related]
22. Evidence for the release of a novel pituitary polypeptide (7B2) from the growth hormone-producing pituitary adenoma of patients with acromegaly.
Natori S; Iguchi H; Nawata H; Kato K; Ibayashi H; Nakagaki H; Chrétien M
J Clin Endocrinol Metab; 1988 Feb; 66(2):430-7. PubMed ID: 3123513
[TBL] [Abstract][Full Text] [Related]
23. Effects of pituitary adenylate cyclase-activating polypeptide on hormone secretion by human pituitary adenomas in vitro.
Desai BJ; Monson JP; Holdstock JG; Aylwin SJ; Geddes JF; Wood DF; Burrin JM
J Clin Endocrinol Metab; 1994 Dec; 79(6):1771-7. PubMed ID: 7527412
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone releasing factor stimulates and somatostatin inhibits prolactin release from human mixed somatotroph-lactotroph adenomas in perifusion.
Serri O
Clin Endocrinol (Oxf); 1987 Dec; 27(6):675-82. PubMed ID: 2901301
[TBL] [Abstract][Full Text] [Related]
25. Characterization of growth hormone-releasing hormone receptors in pituitary adenomas from patients with acromegaly.
Ikuyama S; Natori S; Nawata H; Kato K; Ibayashi H; Kariya T; Sakai T; Rivier J; Vale W
J Clin Endocrinol Metab; 1988 Jun; 66(6):1265-71. PubMed ID: 2836473
[TBL] [Abstract][Full Text] [Related]
26. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
[TBL] [Abstract][Full Text] [Related]
27. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion.
Barkan AL; Shenker Y; Grekin RJ; Vale WW; Lloyd RV; Beals TF
J Clin Endocrinol Metab; 1986 Nov; 63(5):1057-64. PubMed ID: 3093517
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of growth hormone release by vasoactive intestinal polypeptide from human pituitary adenomas in vitro.
Matsushita N; Kato Y; Katakami H; Shimatsu A; Yanaihara N; Imura H
J Clin Endocrinol Metab; 1981 Dec; 53(6):1297-300. PubMed ID: 6795228
[TBL] [Abstract][Full Text] [Related]
29. Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin.
Le Dafniet M; Lefebvre P; Barret A; Mechain C; Feinstein MC; Brandi AM; Peillon F
J Clin Endocrinol Metab; 1990 Aug; 71(2):480-6. PubMed ID: 1974264
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone and prolactin secretion in acromegaly: correlations between hormonal dynamics and immunocytochemical findings.
Bassetti M; Arosio M; Spada A; Brina M; Bazzoni N; Faglia G; Giannattasio G
J Clin Endocrinol Metab; 1988 Dec; 67(6):1195-204. PubMed ID: 3142915
[TBL] [Abstract][Full Text] [Related]
31. Lack of desensitization of adenomatous somatotrophs to growth-hormone releasing hormone in acromegaly.
Spada A; Elahi FR; Arosio M; Sartorio A; Guglielmino L; Vallar L; Faglia G
J Clin Endocrinol Metab; 1987 Mar; 64(3):585-91. PubMed ID: 3102543
[TBL] [Abstract][Full Text] [Related]
32. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW
J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity of pituitary adenoma cell subpopulations from acromegalic patients obtained by Percoll density gradient centrifugation.
Hofland LJ; van Koetsveld PM; Verleun TM; Lamberts SW
Acta Endocrinol (Copenh); 1989 Aug; 121(2):270-8. PubMed ID: 2549755
[TBL] [Abstract][Full Text] [Related]
34. Glycoprotein hormone alpha-subunit and prolactin release by cultured pituitary adenoma cells from acromegalic patients: correlation with GH release.
Hofland LJ; van Koetsveld PM; Verleun TM; Lamberts SW
Clin Endocrinol (Oxf); 1989 Jun; 30(6):601-11. PubMed ID: 2512040
[TBL] [Abstract][Full Text] [Related]
35. The higher the growth hormone response to growth hormone releasing hormone the lower the response to bromocriptine and thyrotrophin releasing hormone in acromegaly.
Smals AE; Pieters GF; Smals AG; Hermus AR; Benraad TJ; Kloppenborg PW
Clin Endocrinol (Oxf); 1987 Jul; 27(1):43-7. PubMed ID: 3115634
[TBL] [Abstract][Full Text] [Related]
36. Secretory mechanisms of growth hormone (GH)-releasing peptide-, GH-releasing hormone-, and thyrotropin-releasing hormone-induced GH release in patients with acromegaly.
Hanew K; Utsumi A; Tanaka A; Ikeda H; Yokogoshi Y
J Clin Endocrinol Metab; 1998 Oct; 83(10):3578-83. PubMed ID: 9768668
[TBL] [Abstract][Full Text] [Related]
37. Pituitary vasoactive intestinal peptide regulates prolactin secretion in the hypothyroid rat.
Lam KS; Reichlin S
Neuroendocrinology; 1989 Nov; 50(5):524-8. PubMed ID: 2514393
[TBL] [Abstract][Full Text] [Related]
38. Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cells.
Saveanu A; Lavaque E; Gunz G; Barlier A; Kim S; Taylor JE; Culler MD; Enjalbert A; Jaquet P
J Clin Endocrinol Metab; 2002 Dec; 87(12):5545-52. PubMed ID: 12466351
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of the inhibitory action of dopamine and somatostatin on prolactin secretion from human lactotrophs in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 Mar; 60(3):599-606. PubMed ID: 2579087
[TBL] [Abstract][Full Text] [Related]
40. Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone.
Joubert D; Benlot C; Lagoguey A; Garnier P; Brandi AM; Gautron JP; Legrand JC; Peillon F
J Clin Endocrinol Metab; 1989 Mar; 68(3):572-7. PubMed ID: 2493037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
